Calciparine and Ototoxicity - a phase IV clinical study of FDA data
Ototoxicity is reported only by a few people who take Calciparine.
The phase IV clinical study analyzes which people take Calciparine and have Ototoxicity. It is created by eHealthMe based on reports of 3,330 people who have side effects while taking Calciparine from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3,330 people reported to have side effects when taking Calciparine.
Among them, 2 people (0.06%) have Ototoxicity.
What is Calciparine?
Calciparine has active ingredients of heparin calcium. eHealthMe is studying from 3,201 Calciparine users for its effectiveness, alternative drugs and more.
What is Ototoxicity?
Ototoxicity (damage to the ear) is found to be associated with 599 drugs and 337 conditions by eHealthMe.
Number of Calciparine and Ototoxicity reports submitted per year:
Gender of people who have Ototoxicity when taking Calciparine *:
- female: 0.0 %
- male: 100 %
Age of people who have Ototoxicity when taking Calciparine *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 100 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common drugs people take besides Calciparine *:
- Xanax: 2 people, 100.00%
- Vfend: 2 people, 100.00%
- Ambisome: 1 person, 50.00%
Common conditions people have *:
- Pseudomonal Bacteraemia (p. aeruginosa cause of bacterial infections of the blood): 2 people, 100.00%
- Meningitis Cryptococcal (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 2 people, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Calciparine and have Ototoxicity?Check whether Ototoxicity is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Ototoxicity and when was it recovered:
Expand to all the drugs that have ingredients of heparin calcium:
Alternative drugs to, pros and cons of Calciparine:
- Calciparine (3,201 reports)
Common Calciparine side effects:
- Acute kidney failure: 180 reports
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 212 reports
- Anaemia (lack of blood): 272 reports
- Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 115 reports
- Eosinophilia (eosinophil count in the peripheral blood exceeds): 144 reports
- Fever: 162 reports
- Haematoma (collection of blood outside the blood vessels): 116 reports
- Rashes (redness): 109 reports
- Renal failure acute (rapid kidney dysfunction): 183 reports
- Thrombocytopenia (decrease of platelets in blood): 343 reports
Browse all side effects of Calciparine:a b c d e f g h i j k l m n o p q r s t u v w x y z
Ototoxicity treatments and more:
- Ototoxicity (1,631 reports)
COVID vaccines that are related to Ototoxicity:
- Ototoxicity in Moderna COVID Vaccine
- Ototoxicity in Pfizer BioNTech Covid Vaccine
- Ototoxicity in Johnson and Johnson Covid Vaccine
Common drugs associated with Ototoxicity:
All the drugs that are associated with Ototoxicity:
- Ototoxicity (599 drugs)
All the conditions that are associated with Ototoxicity:
- Ototoxicity (337 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on heparin calcium (the active ingredients of Calciparine) and Calciparine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Flovent and Social Fear - a second ago
- Gastritis Aggravated and Productive Cough - a second ago
- Lopressor and Blister Infected - a second ago
- Vancomycin Hydrochloride and Protein - Urine - 2 seconds ago
- Dasatinib and Oropharyngeal Candidiasis - 8 seconds ago
- Stress And Anxiety and Gingival Bleeding - 8 seconds ago
- Gemcitabine Hydrochloride and Throat Tightness - 24 seconds ago
- Anaprox and Haematemesis - 25 seconds ago
- Triamcinolone and Death - 29 seconds ago
- Eligard and Toothaches - 32 seconds ago